Activating and inhibitory receptors of natural killer cells (Q37766751)

22 August 2017

1 reference

title

Activating and inhibitory receptors of natural killer cells (English)

1 reference

22 August 2017

Michael H Kershaw

5

0 references

Phillip K. Darcy

object named as

Phillip K Darcy

series ordinal

4

0 references

Mark J. Smyth

object named as

Mark J Smyth

series ordinal

3

0 references

Hollie J Pegram

series ordinal

1

object named as

Hollie J Pegram

1 reference

22 August 2017

Daniel M Andrews

2

1 reference

22 August 2017

22 June 2010

1 reference

Immunology & Cell Biology

22 August 2017

1 reference

22 August 2017

89

1 reference

22 August 2017

216-224

1 reference

22 August 2017

2

1 reference

Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study

22 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Immunophenotyping of blood lymphocytes in childhood. Reference values for lymphocyte subpopulations

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Trafficking of natural killer cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

The dynamic life of natural killer cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

NK cell compartments and their activation by dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Variable receptors controlling activation and inhibition of NK cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

In search of the 'missing self': MHC molecules and NK cell recognition

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

The NKG2D receptor and its ligands-recognition beyond the "missing self"?

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Arousal and inhibition of human NK cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Natural killer cell recognition of missing self

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Signaling pathways engaged by NK cell receptors: double concerto for activating receptors, inhibitory receptors and NK cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

An essential function for beta-arrestin 2 in the inhibitory signaling of natural killer cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Minimal requirement for induction of natural cytotoxicity and intersection of activation signals by inhibitory receptors.

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Inhibitory receptor signaling via tyrosine phosphorylation of the adaptor Crk

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

NK cell-activating receptors require PKC-theta for sustained signaling, transcriptional activation, and IFN-gamma secretion.

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

An activating immunoreceptor complex formed by NKG2D and DAP10

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

UL16-binding proteins, novel MHC class I-related proteins, bind to NKG2D and activate multiple signaling pathways in primary NK cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

NKG2D triggers cytotoxicity in mouse NK cells lacking DAP12 or Syk family kinases.

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

NKG2D-DAP10 triggers human NK cell–mediated killing via a Syk-independent regulatory pathway

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

NK cell regulation by SLAM family receptors and SAP-related adapters

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

KIR2DL4 (CD158d), an NK cell-activating receptor with inhibitory potential

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Crystal structure of a lectin-like natural killer cell receptor bound to its MHC class I ligand

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Variable MHC class I engagement by Ly49 natural killer cell receptors demonstrated by the crystal structure of Ly49C bound to H-2K(b)

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Interaction of Ly-49D+ NK cells with H-2Dd target cells leads to Dap-12 phosphorylation and IFN-gamma secretion

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Activating Ly-49 NK receptors: central role in cytokine and chemokine production

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Ly-49W, an activating receptor of nonobese diabetic mice with close homology to the inhibitory receptor Ly-49G, recognizes H-2D(k) and H-2D(d).

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Ly-49P activates NK-mediated lysis by recognizing H-2Dd.

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

The natural killer cell receptor Ly-49A recognizes a peptide-induced conformational determinant on its major histocompatibility complex class I ligand

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Binding of diverse peptides to MHC class I molecules inhibits target cell lysis by activated natural killer cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Direct assessment of MHC class I binding by seven Ly49 inhibitory NK cell receptors.

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Cis association of Ly49A with MHC class I restricts natural killer cell inhibition

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Interactions of Ly49 family receptors with MHC class I ligands in trans and cis

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Acquisition of MHC-specific receptors on murine natural killer cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Specificity, tolerance and developmental regulation of natural killer cells defined by expression of class I-specific Ly49 receptors

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Ly49A allelic variation and MHC class I specificity.

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Divergent and convergent evolution of NK-cell receptors

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Natural selection drives recurrent formation of activating killer cell immunoglobulin-like receptor and Ly49 from inhibitory homologues

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

DNA methylation maintains allele-specific KIR gene expression in human natural killer cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

KIR acquisition probabilities are independent of self-HLA class I ligands and increase with cellular KIR expression.

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Tyrosine phosphorylation of a human killer inhibitory receptor recruits protein tyrosine phosphatase 1C

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

https://api.crossref.org/works/10.1038%2FICB.2010.78

1 reference

7 January 2021

Recognition of HLA-A3 and HLA-A11 by KIR3DL2 is peptide-specific.

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Peptide specificity in the recognition of MHC class I by natural killer cell clones

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

A p70 killer cell inhibitory receptor specific for several HLA-B allotypes discriminates among peptides bound to HLA-B*2705.

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

HLA-A11-mediated protection from NK cell-mediated lysis: role of HLA-A11-presented peptides

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Peptides isolated from HLA-Cw*0304 confer different degrees of protection from natural killer cell-mediated lysis

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

A structural perspective on MHC class I recognition by killer cell immunoglobulin-like receptors

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Molecular Architecture of the Major Histocompatibility Complex Class I-binding Site of Ly49 Natural Killer Cell Receptors

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Killer cell immunoglobulin-like receptors on NK cells: the how, where and why.

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Licensing of natural killer cells by self-major histocompatibility complex class I.

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Licensing of natural killer cells by host major histocompatibility complex class I molecules

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Human NK cell education by inhibitory receptors for MHC class I.

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

HLA alleles determine differences in human natural killer cell responsiveness and potency

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Regulation of the natural killer cell receptor repertoire

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Heterogeneous phenotypes of expression of the NKB1 natural killer cell class I receptor among individuals of different human histocompatibility leukocyte antigens types appear genetically regulated, but not linked to major histocompatibililty comple

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

The repertoire of HLA-Cw-specific NK cell receptors CD158 a/b (EB6 and GL183) in individuals with different HLA phenotypes

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

KIR: diverse, rapidly evolving receptors of innate and adaptive immunity

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Inhibitory killer Ig-like receptor genes and human leukocyte antigen class I ligands in haematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

HLA class I-specific inhibitory receptors in human T lymphocytes: interleukin 15-induced expression of CD94/NKG2A in superantigen- or alloantigen-activated CD8+ T cells.

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Transforming growth factor-beta-induced expression of CD94/NKG2A inhibitory receptors in human T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Expression of CD94/NKG2-A on human T lymphocytes is induced by IL-12: implications for adoptive immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b)

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Association of DAP12 with activating CD94/NKG2C NK cell receptors

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

The CD94 and NKG2-A C-type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

A signal peptide derived from hsp60 binds HLA-E and interferes with CD94/NKG2A recognition

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

The role of the NKG2D immunoreceptor in immune cell activation and natural killing

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

The activating NKG2D receptor assembles in the membrane with two signaling dimers into a hexameric structure.

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Up on the tightrope: natural killer cell activation and inhibition

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Thermodynamic analysis of degenerate recognition by the NKG2D immunoreceptor: not induced fit but rigid adaptation

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Role of the heat shock response and molecular chaperones in oncogenesis and cell death

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Human microRNAs regulate stress-induced immune responses mediated by the receptor NKG2D.

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Interactions of human NKG2D with its ligands MICA, MICB, and homologs of the mouse RAE-1 protein family

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Expression and role of MICA and MICB in human hepatocellular carcinomas and their regulation by retinoic acid

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Cutting edge: murine UL16-binding protein-like transcript 1: a newly described transcript encoding a high-affinity ligand for murine NKG2D.

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Molecular Competition for NKG2D

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Cutting edge: Toll-like receptor signaling in macrophages induces ligands for the NKG2D receptor

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Regulation of cutaneous malignancy by gammadelta T cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Posttranslational regulation of the NKG2D ligand Mult1 in response to cell stress

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Cutting edge: novel priming of tumor-specific immunity by NKG2D-triggered NK cell-mediated tumor rejection and Th1-independent CD4+ T cell pathway

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Cutting Edge: Down-Regulation of MICA on Human Tumors by Proteolytic Shedding

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

TGF-beta and metalloproteinases differentially suppress NKG2D ligand surface expression on malignant glioma cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

NKp44 expression, phylogenesis and function in non-human primate NK cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Paradoxic inhibition of human natural interferon-producing cells by the activating receptor NKp44.

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

https://api.crossref.org/works/10.1038%2FICB.2010.78

1 reference

7 January 2021

Recognition of viral hemagglutinins by NKp44 but not by NKp30.

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Natural killer cells in cancer

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Human leukocyte antigen-B-associated transcript 3 is released from tumor cells and engages the NKp30 receptor on natural killer cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Membrane-associated heparan sulfate proteoglycans are involved in the recognition of cellular targets by NKp30 and NKp46.

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Mutual activation of natural killer cells and monocytes mediated by NKp80-AICL interaction.

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Enhanced in vivo growth of lymphoma tumors in the absence of the NK-activating receptor NKp46/NCR1.

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Natural killer cells and dendritic cells: rendezvous in abused tissues

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Structural basis for recognition of the nonclassical MHC molecule HLA-G by the leukocyte Ig-like receptor B2 (LILRB2/LIR2/ILT4/CD85d)

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18.

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Modulation of natural killer cell cytotoxicity in human cytomegalovirus infection: the role of endogenous class I major histocompatibility complex and a viral class I homolog

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

2B4, the natural killer and T cell immunoglobulin superfamily surface protein, is a ligand for CD48

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Identification of a novel signal transduction surface molecule on human cytotoxic lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

2B4 acts as a non-major histocompatibility complex binding inhibitory receptor on mouse natural killer cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

2B4 (CD244) is a non-MHC binding receptor with multiple functions on natural killer cells and CD8+ T cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

https://api.crossref.org/works/10.1038%2FICB.2010.78

1 reference

7 January 2021

Functional role of human NK cell receptor 2B4 (CD244) isoforms

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Characterization of inhibitory and stimulatory forms of the murine natural killer cell receptor 2B4.

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Targeted disruption of the 2B4 gene in mice reveals an in vivo role of 2B4 (CD244) in the rejection of B16 melanoma cells.

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Cutting edge: inhibitory functions of the killer cell lectin-like receptor G1 molecule during the activation of mouse NK cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Killer cell lectin-like receptor G1 binds three members of the classical cadherin family to inhibit NK cell cytotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Cadherins and catenins in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Cadherins and cancer: how does cadherin dysfunction promote tumor progression?

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Cytolytic responses: cadherins put out the fire

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Identification of a cell-surface antigen selectively expressed on the natural killer cell

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Cloning of Clr, a new family of lectin-like genes localized between mouse Nkrp1a and Cd69

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Association with FcRgamma is essential for activation signal through NKR-P1 (CD161) in natural killer (NK) cells and NK1.1+ T cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

CD161 (human NKR-P1A) signaling in NK cells involves the activation of acid sphingomyelinase

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Missing self-recognition of Ocil/Clr-b by inhibitory NKR-P1 natural killer cell receptors

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Analysis of a 1-Mb BAC contig overlapping the mouse Nkrp1 cluster of genes: cloning of three new Nkrp1 members, Nkrp1d, Nkrp1e, and Nkrp1f.

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

NKR-P1 biology: from prototype to missing self

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Functional characterization of DNAM-1 (CD226) interaction with its ligands PVR (CD155) and nectin-2 (PRR-2/CD112)

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Overexpression of the CD155 gene in human colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

ATM-ATR-dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

DNAM-1 promotes activation of cytotoxic lymphocytes by nonprofessional antigen-presenting cells and tumors

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Accelerated tumor growth in mice deficient in DNAM-1 receptor

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

DNAM-1/CD155 interactions promote cytokine and NK cell-mediated suppression of poorly immunogenic melanoma metastases

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

DNAM-1 and PVR regulate monocyte migration through endothelial junctions

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Physical and functional association of LFA-1 with DNAM-1 adhesion molecule

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

IL-15-mediated induction of LFA-1 is a late step required for cytotoxic differentiation of human NK cells from CD34+Lin- bone marrow cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Dissecting natural killer cell activation pathways through analysis of genetic mutations in human and mouse

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

CD226 is specifically expressed on the surface of Th1 cells and regulates their expansion and effector functions

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

CD226 (DNAM-1) is involved in lymphocyte function-associated antigen 1 costimulatory signal for naive T cell differentiation and proliferation

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Activation of natural killer cells and dendritic cells upon recognition of a novel CD99-like ligand by paired immunoglobulin-like type 2 receptor

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

PILRalpha, a novel immunoreceptor tyrosine-based inhibitory motif-bearing protein, recruits SHP-1 upon tyrosine phosphorylation and is paired with the truncated counterpart PILRbeta

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

An essential role of sialylated O-linked sugar chains in the recognition of mouse CD99 by paired Ig-like type 2 receptor (PILR)

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.78

7 January 2021

Identifiers

DOI

10.1038/ICB.2010.78

1 reference

22 August 2017

1 reference

PubMed ID

20567250